Breaking News Instant updates and real-time market news.

VRCA

Verrica Pharmaceuticals

$9.18

-0.26 (-2.75%)

10:41
06/27/19
06/27
10:41
06/27/19
10:41

Verrica Pharmaceuticals price target raised to $23 from $20 at H.C. Wainwright

H.C. Wainwright analyst Oren Livnat raised his price target for Verrica Pharmaceuticals to $23 from $20 after the company announced "positive results" of the open-label Phase 2 trial of VP-102, topical cantharidin drug-device combination, in common warts. The analyst says his Buy rating and prior target were entirely based on VP-102 for molluscum contagiosum. He sees around $220M in peak warts sales.

VRCA Verrica Pharmaceuticals
$9.18

-0.26 (-2.75%)

06/27/19
JEFF
06/27/19
NO CHANGE
Target $24
JEFF
Buy
Verrica reported positive Phase 2 results in underserved market, says Jefferies
Verrica Pharmaceuticals last night announced positive Phase 2 results for VP-102 in common warts, a "large underserved" indication impacting 22M Americans, Jefferies analyst David Steinberg tells investors in a research note. The analyst believes that if successfully developed, VP-102 could reach the market in the second half of 2022 as Verrica's second major indication after molluscum. He keeps a Buy rating on the shares with a $24 price target.
05/15/19
HCWC
05/15/19
NO CHANGE
Target $20
HCWC
Buy
Verrica opportunity in molluscum 'far undervalued," says H.C. Wainwright
H.C. Wainwright analyst Oren Livnat says the recent weakness in shares of Verrica Pharmaceuticals is "unexplained" as the company remains on track for a VP-102 molluscum new drug application filing in the second half of 2019. Only final stability testing and manufacturing are gating factors for the application filing, and final approval in the second half of 2020 is "relatively low risk" given the statistically significant Phase 3 data and the unmet need in the indication, Livnat tells investors in a research note. The analyst remains bullish on Verrica's molluscum opportunity, projecting $400M "peak high-margin" sales in the U.S. He thinks this is "far undervalued in Verrica's current $160M enterprise value." The analyst reiterates a Buy rating on Verrica Pharmaceuticals with a $20 price target.
02/21/19
02/21/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. At Home Group (HOME) initiated with a Hold at Loop Capital. 2. Harmonic (HLIT) initiated with a Buy at Stifel. 3. Atkore (ATKR) initiated with a Neutral at Credit Suisse. 4. BioTime (BTX) and Verrica Pharmaceuticals (VRCA) were initiated with a Buy at H.C. Wainwright. 5. Aphria (APHA), KushCo Holdings (KSHB), and HEXO Corp (HEXO) were initiated with a Buy at Seaport Global, while Canopy Growth (CGC), Aurora Cannabis (ACB), and Tilray (TLRY) were initiated with a Neutral. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
02/21/19
HCWC
02/21/19
INITIATION
Target $20
HCWC
Buy
Verrica Pharmaceuticals initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Oren Livnat started Verrica Pharmaceuticals with a Buy rating and $20 price target. The analyst's valuation is based solely on Verrica's lead candidate, VP-102, for molluscum, a pediatric viral skin infection. VP-102 has recently demonstrated robust Phase 3 efficacy, says the analyst, who projects a late-2020 launch. He projects $400M peak U.S. sales in molluscum.

TODAY'S FREE FLY STORIES

CDEV

Centennial Resource Development

$6.59

-0.305 (-4.42%)

04:48
07/17/19
07/17
04:48
07/17/19
04:48
Downgrade
Centennial Resource Development rating change  »

Centennial Resource…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JAG

Jagged Peak Energy

$8.09

-0.23 (-2.76%)

04:46
07/17/19
07/17
04:46
07/17/19
04:46
Downgrade
Jagged Peak Energy rating change  »

Jagged Peak Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Aug

NLS

Nautilus

$1.74

0.09 (5.45%)

04:44
07/17/19
07/17
04:44
07/17/19
04:44
Upgrade
Nautilus rating change  »

Nautilus upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

SND

Smart Sand

$2.35

-0.04 (-1.67%)

04:40
07/17/19
07/17
04:40
07/17/19
04:40
Upgrade
Smart Sand rating change  »

Smart Sand upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

  • 27

    Aug

OPRA

Opera

$10.59

-0.16 (-1.49%)

04:39
07/17/19
07/17
04:39
07/17/19
04:39
Initiation
Opera initiated  »

Opera initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARLP

Alliance Resource Partners

$17.25

-0.26 (-1.48%)

04:39
07/17/19
07/17
04:39
07/17/19
04:39
Downgrade
Alliance Resource Partners rating change  »

Alliance Resource…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

WFC

Wells Fargo

$45.30

-1.4 (-3.00%)

04:33
07/17/19
07/17
04:33
07/17/19
04:33
Downgrade
Wells Fargo rating change  »

Wells Fargo downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Oct

DOYU

DouYu

$0.00

(0.00%)

04:29
07/17/19
07/17
04:29
07/17/19
04:29
Syndicate
DouYu 67.387M share IPO priced at $11.50 »

The deal priced at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

AVRO

Avrobio

$19.08

2.66 (16.20%)

04:25
07/17/19
07/17
04:25
07/17/19
04:25
Syndicate
Avrobio 6.5M share Secondary priced at $18.50 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 17

    Jul

RGEN

Repligen

$88.44

2.57 (2.99%)

04:23
07/17/19
07/17
04:23
07/17/19
04:23
Syndicate
Repligen 1.38M share Secondary priced at $87.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 19

    Sep

  • 13

    Nov

  • 17

    Jul

04:10
07/17/19
07/17
04:10
07/17/19
04:10
General news
FX Action: USD-CAD printed a five-session high »

FX Action: USD-CAD…

02:55
07/17/19
07/17
02:55
07/17/19
02:55
General news
FX Update: The dollar has settled to a consolidation »

FX Update: The dollar has…

02:10
07/17/19
07/17
02:10
07/17/19
02:10
General news
Asian Market Wrap: »

Asian Market Wrap:…

ATEX

Anterix

$46.95

-0.66 (-1.39%)

21:10
07/16/19
07/16
21:10
07/16/19
21:10
Syndicate
Anterix 2.22M share Secondary priced at $45.00 »

The deal priced below the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

  • 17

    Jul

TNXP

Tonix Pharmaceuticals

$0.57

-0.4087 (-41.75%)

21:08
07/16/19
07/16
21:08
07/16/19
21:08
Syndicate
Tonix Pharmaceuticals 9M share Secondary priced at $0.60 »

Aegis is acting as sole…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 16

    Jul

HTHT

Huazhu Group

$34.88

0.23 (0.66%)

21:05
07/16/19
07/16
21:05
07/16/19
21:05
Earnings
Huazhu Group sees Q2 revenue growth of 13%-15% »

Reports Q2 blended…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PS

Pluralsight

$30.66

-0.71 (-2.26%)

20:58
07/16/19
07/16
20:58
07/16/19
20:58
Initiation
Pluralsight initiated at KeyBanc »

Pluralsight initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

TWOU

2U

$38.60

-0.34 (-0.87%)

20:57
07/16/19
07/16
20:57
07/16/19
20:57
Initiation
2U initiated at KeyBanc »

2U initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BVN

Buenaventura

$16.31

-0.03 (-0.18%)

20:36
07/16/19
07/16
20:36
07/16/19
20:36
Hot Stocks
Buenaventura reports Q2 Orcopampa gold production 10.7K oz vs. 5.9K in Q1 »

The company also lowers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

HOPE

Hope Bancorp

$13.96

0.2 (1.45%)

20:33
07/16/19
07/16
20:33
07/16/19
20:33
Hot Stocks
Hope Bancorp authorizes $50M stock repurchase program »

Hope Bancorp announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

20:25
07/16/19
07/16
20:25
07/16/19
20:25
Conference/Events
CLSA Asian tech analyst team to hold an analyst/industry conference call »

Asian Technology Analysts…

BAC

Bank of America

$28.99

-0.23 (-0.79%)

, ABT

Abbott

$83.11

-0.69 (-0.82%)

20:25
07/16/19
07/16
20:25
07/16/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

BAC

Bank of America

$28.99

-0.23 (-0.79%)

ABT

Abbott

$83.11

-0.69 (-0.82%)

USB

U.S. Bancorp

$53.04

-0.07 (-0.13%)

PNC

PNC Financial

$138.66

-1.52 (-1.08%)

PGR

Progressive

$84.11

0.105 (0.12%)

BK

BNY Mellon

$43.13

-0.02 (-0.05%)

OMC

Omnicom

$84.08

0.065 (0.08%)

TXT

Textron

$54.02

0.59 (1.10%)

CMA

Comerica

$71.75

0.39 (0.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 17

    Jul

  • 17

    Jul

  • 17

    Jul

  • 17

    Jul

  • 17

    Jul

  • 17

    Jul

  • 17

    Jul

  • 17

    Jul

  • 06

    Aug

  • 06

    Aug

  • 08

    Aug

  • 26

    Aug

  • 06

    Sep

  • 16

    Oct

SCGLY

Societe Generale

$0.00

(0.00%)

20:08
07/16/19
07/16
20:08
07/16/19
20:08
Upgrade
Societe Generale rating change at JPMorgan »

Societe Generale upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$299.75

-1.03 (-0.34%)

, SPX

S&P 500

$0.00

(0.00%)

20:06
07/16/19
07/16
20:06
07/16/19
20:06
Periodicals
SF Fed President Daly not leaning in either direction on rates, Reuters says »

In a Reuters interview,…

SPY

SPDR S&P 500 ETF Trust

$299.75

-1.03 (-0.34%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WAFD

Washington Federal

$34.63

0.02 (0.06%)

20:02
07/16/19
07/16
20:02
07/16/19
20:02
Earnings
Washington Federal reports Q3 EPS 67c, consensus 64c »

Reports Q3 NII $121.7M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.